Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of rivaroxaban tablets in healthy Chinese adults under fasting and fed conditions
ChiCTR2200058669Phase 4Completed
- Sponsor
- Guangzhou Panyu District Central Hospital
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rivaroxaban in thrombosis (4 arms), sponsored by Guangzhou Panyu District Central Hospital. Primary endpoint: Rivaroxaban plasma concentration at 48 hours. Started Mar 2018; status: completed.
02
Drugs
rivaroxaban
03
Conditions
thrombosis
Beyond the preview
Go deeper on ChiCTR2200058669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058669.